ixekizumab [Supplementary Concept]
A humanized anti-interleukin 17 monoclonal antibody used for the treatment of PSORIASIS.
Date introduced: May 3, 2010
MeSH Unique ID: C549079
Registry Number: BTY153760O
Heading Mapped to:
Entry Terms:
Previous Indexing:
Pharmacologic Action: